Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
AstraZeneca PLC · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $82.31B | $77.76B - $84.82B | $42.66B | $16.786 | 10 |
| Dec 2029 | $77.49B | $73.21B - $79.85B | $40.16B | $15.018 | 10 |
| Dec 2028 | $72.25B | $71.89B - $72.61B | $37.44B | $13.003 | 21 |
| Dec 2027 | $67.87B | $64.61B - $69.79B | $35.17B | $11.649 | 18 |
| Dec 2026 | $63.42B | $62.39B - $64.38B | $32.87B | $10.272 | 17 |
| Dec 2025 | $58.65B | $57.37B - $59.41B | $30.39B | $9.159 | 15 |
| Dec 2024 | $53.12B | $52.59B - $53.49B | $27.53B | $8.21 | 14 |
| Dec 2023 | $49.13B | $46.42B - $50.63B | $25.46B | $4.158 | 13 |
| Dec 2022 | $44.44B | $44.42B - $44.46B | $7.57B | $3.359 | 2 |
| Dec 2021 | $36.41B | $34.62B - $37.29B | $7.28B | $2.593 | 3 |
| Dec 2020 | $26.38B | $25.08B - $27.01B | $8.26B | $2.094 | 3 |
| Dec 2019 | $24.36B | $23.17B - $24.95B | $6.76B | $1.794 | 2 |